RADIOLOGY /// NEURO

AI-enabled solution to help providers with brain tumor diagnosis and follow-up

Tempus Pixel provides advanced analysis and automated reporting of routine neuro-MR images to help inform brain tumor diagnosis, delineate resection extent, monitor post-op, and identify recurrences.^1,2

Zero-click perfusion maps

Rapidly generates MR perfusion maps that can inform diagnostic and treatment decisions, ≥85% accuracy in differentiating between tumor progression and treatment effect^1,2,3

Automated brain imaging analysis

Reduces tedious manual tasks and increases productivity by generating quantitative diffusion, perfusion, and DeltaT1 maps for aiding brain tumor management^1,3

Automated artifact correction

Standardizes quantitative assessment by minimizing rCBV maps artifacts caused by contrast agent leakage to enable consistent brain perfusion assessments^1,3

Tempus Pixel Neuro is powered by Imaging Biometrics’ IB Neuro and IB Clinic, which are FDA-cleared under (K080762) and (K123302) and have been CE marked. Arterys Inc is the manufacturer of Tempus Pixel Neuro, excluding any third party components described in this list. Imaging BioMetrics is the manufacturer of IB Neuro.
Prah MA, Al-Gizawiy MM, Mueller WM, et al. Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics. J Neurooncol. 2018;136(1):13-21. doi.org/10.1007/s11060-017-2617-3
Hu LS, Kelm Z, Korfiatis P, et al. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma. Am J Neuroradiol. 2015;36(12):2242-2249. doi.org/10.3174/ajnr.A4451